Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
12.05.26
/
50%
€63.94
Target price
12.05.27
€82.50
Performance (%)
7.16%
Price
19.06.26
€68.52
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 7.16%. This prediction currently runs until 12.05.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 12.995% | 12.995% |
| iShares Core DAX® | 1,35 % | 2,74 % |
| iShares Nasdaq 100 | 3,28 % | 6,51 % |
| iShares Nikkei 225® | 7,43 % | 17,83 % |
| iShares S&P 500 | 1,70 % | 3,10 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $92.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
17.03.26
17.03.26
€65.24
17.03.27
17.03.27
26.89%
19.06.26
19.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€54.00
20.01.26
20.01.26
€63.57
20.01.27
20.01.27
26.89%
19.06.26
19.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
101.52%
10.06.26
10.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25

